ICICI Prudential Nifty Pharma Index Fund Direct growth

Equity • Index • Direct growth

CAGRInfo Icon

₹1,000 invested for 5 years

Fund Info

Equity

Index

Direct growth

Launched On
15 Dec 2022
1.9 years ago
Lock-in Period
No lock-in
NAV
as of 22 Nov 2024
₹16.92
+1.0186% (0.20)
AUM
₹75 Cr
Expense ratio
0.35%
Benchmark
Nifty Pharma
Fund Plan
Open demat account

Get access to more insightful information

By signing up to Upstox today

Tax info and exit loadInfo Icon

Taxes

Units held less than 1Y

20%

Units held more than 1Y

12.5%

Exit Load

If units sold anytime

0%

What's in this fund?

Sectors
Holdings
Healthcare

Healthcare

100.00%

Fund House

ICICI Prudential

ICICI Prudential

Inc: 01 Oct 1994 • Total AUM: ₹5,55,710 Cr • Rank #3
ICICI Prudential Mutual Fund, started in 1998, has ICICI Bank as its sponsor. The fund house is headed by Nimesh Shah as the CEO. As of 31 March 2024, it has an AUM of ₹7,61,780 Cr. Its reach is spread across over 350 locations and an investor base of more than 9.2 million investors (as of November 2023).

Fund Managers

Nishit Patel

Experience: 3.89 yrs • Total AUM: 2,51,583 Cr

Priya Sridhar

Experience: 0.79 yrs • Total AUM: 2,28,444 Cr

Risk

Category risk
Very high
As provided by the fund house document, this risk is specific to this fund category (Equity). To know the risk of this fund particularly, check 'Risk vs Category'.

Other top rated funds

Top rated

UTI Nifty Next 50 Index Fund

Equity • Index • Direct Growth
3Y CAGR
17.19%
Expense ratio
0.36%
Tracking error
Below Average
Fund size
High
Top rated

ICICI Prudential Nifty Next 50 Index

Equity • Index • Direct Growth
3Y CAGR
17.17%
Expense ratio
0.31%
Tracking error
Below Average
Fund size
High
Top rated

SBI Nifty Index Fund

Equity • Index • Direct Growth
3Y CAGR
12.19%
Expense ratio
0.2%
Tracking error
Low
Fund size
High
Top rated

UTI Nifty 50 Index Fund

Equity • Index • Direct Growth
3Y CAGR
12.19%
Expense ratio
0.19%
Tracking error
Low
Fund size
High
Top rated

ICICI Prudential Nifty 50 Index Fund

Equity • Index • Direct Growth
3Y CAGR
12.16%
Expense ratio
0.17%
Tracking error
Low
Fund size
High
1 / 5
Disclaimer: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.